Edition:
United States

People: Cascadian Therapeutics Inc (CASC.O)

CASC.O on Nasdaq

4.01USD
20 Sep 2017
Change (% chg)

$0.13 (+3.35%)
Prev Close
$3.88
Open
$3.86
Day's High
$4.09
Day's Low
$3.84
Volume
200,000
Avg. Vol
338,738
52-wk High
$10.98
52-wk Low
$3.18

Azelby, Robert 

Mr. Robert W. Azelby has been appointed as Director of the Company effective as of March 31, 2017. He has served as Chief Commercial Officer at Juno Therapeutics since November 2015. Prior to Juno, he was with Amgen for 15 years, serving most recently as Vice President and General Manager of Amgen's $6 billion U.S. Oncology business.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --